-

Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN) breached their fiduciary duties to Regeneron and its shareholders. If you are a Regeneron shareholder, you are encouraged to contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether Regeneron’s board of directors or senior management failed to manage Regeneron in an acceptable manner, in breach of their fiduciary duties to Regeneron, and whether Regeneron has suffered damages as a result.

In January 2017, Regeneron received a subpoena from the U.S. Attorney’s Office for the District of Massachusetts regarding violations of federal anti-kickback statutes concerning use of patient-assistance funds to encourage doctors to prescribe certain of Regeneron’s drugs over less-expensive competitors.

In September 2019, Regeneron received a civil investigative demand from the U.S. Department of Justice pursuant to the federal False Claims Act investigating separate violations of federal anti-kickback statutes.

On June 24, 2020, federal prosecutors in Massachusetts filed suit against Regeneron, claiming violations of federal anti-kickback statutes.

What You Can Do

If you are a Regeneron shareholder, you may have legal claims against Regeneron’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, Ohio, and Virginia.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, NY, New York 10169
(844) 818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NASDAQ:REGN

Release Summary
Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharma, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN)
Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, NY, New York 10169
(844) 818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM)

NEW YORK--(BUSINESS WIRE)--The lead plaintiff deadline throughout the release dated February 6, 2026, should read April 13, 2026 (instead of April 6, 2026). The updated release reads: SCOTT+SCOTT ATTORNEYS AT LAW LLP FILES SECURITIES CLASS ACTION AGAINST POMDOCTOR, LTD. (NASDAQ: POM) Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants PomDoctor Ltd., Zhenyan...

CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Picard Medical Inc. (NASDAQ: PMI)

NEW YORK--(BUSINESS WIRE)--The lead plaintiff deadline throughout the release dated February 3, 2026, should read April 13, 2026 (instead of April 3, 2026). The updated release reads: SCOTT+SCOTT ATTORNEYS AT LAW LLP FILES SECURITIES CLASS ACTION AGAINST PICARD MEDICAL INC. (NASDAQ: PMI) Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Picard Medical Inc....

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Hub Group, Inc. (NASDAQ: HUBG)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Hub Group is a transport...
Back to Newsroom